Clinical trial
Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive…
NCT00115245 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00115245 |
|---|---|
| Title | Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B |
| Official title | A Randomized, Open-Label Trial of Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B |
| Lead sponsor | Novartis, Industry |
| Collaborators | Novartis Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | Telbivudine (LdT), Adefovir Dipivoxil |
| Start date | Nov 1, 2004 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Jun 22, 2005 |
| Last update posted | May 12, 2015 |
| Countries | Australia, Canada, China, France, Singapore, South Korea, Taiwan, Thailand, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: